Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin: Updated Patient Access Scheme (PAS) submission from Forest Laboratories UK
|
Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin: Updated Patient Access Scheme (PAS) submission from Forest Laboratories UK
25 January 2013 (812.41 Kb 56 sec) |
This page was last updated: 23 January 2013